Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.
about
Interventions to prevent steroid-induced osteoporosis and osteoporotic fractures in Duchenne muscular dystrophyImpact of Dental Implant Surface Modifications on OsseointegrationPosition Statement: Drug Holiday in Osteoporosis Treatment with Bisphosphonates in South KoreaMedication Related Osteonecrosis of the Jaw: 2015 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial SurgeonsManaging Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral ResearchOral bisphosphonates and colon cancer: an updateBisphosphonate Related Osteonecrosis of the Jaw: An UpdatePostmenopausal osteoporosis treatment with antiresorptives: effects of discontinuation or long-term continuation on bone turnover and fracture risk--a perspectiveUpdates on mechanism of action and clinical efficacy of risedronate in osteoporosisManaging osteoporosis in ulcerative colitis: something new?Bisphosphonate drug holiday: choosing appropriate candidatesDenosumab: mechanism of action and clinical outcomesExposure to bisphosphonates and risk of colorectal cancerDental complications and management of patients on bisphosphonate therapy: A review articleDiscovery of Novel Allosteric Non-Bisphosphonate Inhibitors of Farnesyl Pyrophosphate Synthase by Integrated Lead FindingIncreasing options for the treatment of osteoporosisControlled delivery of zoledronate improved bone formation locally in vivoPrenylated Polyphenols from Clusiaceae and Calophyllaceae with Immunomodulatory Activity on Endothelial CellsAlterations of mass density and 3D osteocyte lacunar properties in bisphosphonate-related osteonecrotic human jaw bone, a synchrotron µCT study.Treatment of bone marrow lesions (bone marrow edema).The effect of medications which cause inflammation of the gastro-oesophageal tract on cancer risk: a nested case-control study of routine Scottish data.Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronateAssociation between alendronate and atypical femur fractures: a meta-analysis.Bisphosphonates and bone quality.Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.Longitudinal Change in Trabecular Bone Score during and after Treatment of Osteoporosis in Postmenopausal Korean WomenDirect antitumour activity of zoledronic acid: preclinical and clinical data.Novel Radiolabeled Bisphosphonates for PET Diagnosis and Endoradiotherapy of Bone MetastasesSmart, programmable and responsive injectable hydrogels for controlled release of cargo osteoporosis drugs.The effect of antiresorptives on bone quality.Morphological assessment of basic multicellular unit resorption parameters in dogs shows additional mechanisms of bisphosphonate effects on bone.Isoprenoids, small GTPases and Alzheimer's disease.Risedronate's efficacy: from randomized clinical trials to real clinical practice.Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosisLong-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.Update on estrogens and the skeletonAn NMR metabolomic study on the effect of alendronate in ovariectomized mice.The role of zoledronic acid in the adjuvant treatment of breast cancer: current perspectives.Effect of local zoledronate on implant osseointegration in a rat modelIncrease in the serum parathyroid hormone level during a bisphosphonate drug holiday.
P2860
Q24198280-942B43F3-BB99-42E0-ABB7-417BC5FF8E96Q26740183-EA7E5465-0DA3-4192-9A7F-D05182FE6C10Q26771713-314A5417-68F5-4F71-8B39-38A65F23C2D6Q26771715-FC1C3252-ADB9-421D-B3E2-48ED0E960CBFQ26782621-A2D610F8-445F-450D-81DD-5784707FC843Q26796479-F875A1C0-4E13-4E7B-ABA1-33EC5C204647Q26801664-73DC8395-4D3C-4557-9141-342BC617374AQ26864207-C2940170-84CE-4A0A-8BB8-7240F3C92EFFQ26864549-FFE5C1F4-F84E-4180-8BB7-DE73966B1E08Q26864691-5B5D2661-096E-441E-AA26-684F364385F6Q27004682-324A9CCC-4785-46A9-B45E-E46CB80E21D2Q27015899-B5691618-EAFE-4C2F-A36C-C9782FAF4A11Q27022446-BD71B7AF-DCC8-4B73-BB3B-41B23E9C12A4Q27022492-26865FF5-C1DA-4ADB-BBC9-E3D57866E3EEQ27702178-73F2D602-FA8B-4B48-B444-37189DE2C522Q28254516-C64DF36E-BC39-4163-8EFB-968DB28042EAQ28540762-BA24A516-D831-4CD8-BC3C-DE46D6F4B51BQ28554642-59145345-E77C-4663-9681-3A2E7B3119DEQ30442689-110A7357-5A92-47C6-9E6A-2BF6079DB7D0Q31030762-682FFC70-182D-48ED-A876-5094CEDE4388Q31156585-0F4660F9-C34B-4E76-9CC1-E001FF111E49Q33587793-A8278B99-4883-4061-AE7C-7FDD722833C2Q33596535-038E1373-581B-4AC4-B77C-BBE2E90EEFA9Q33683219-5CA8CB6E-AA81-49EE-B1CA-B06836B48CB5Q33715141-E8519D88-DB5D-4A28-BA45-0E3D48892981Q33804839-56B337A9-FEF9-490D-8DE4-3E4738BBCC43Q33850938-D87A393B-F9C6-4512-8402-A2D2B6647962Q33851523-DE82D735-43A9-4863-95F9-0F4FE3FA1E09Q33881531-B806D858-6F75-4C3E-8299-C54740B7E0D3Q33896122-152492B5-490A-4895-9996-5A365409321BQ33914500-5D137AFC-40B7-4F1E-92EF-B0C486BA590CQ33915441-9A831AB0-ECE0-4F95-B972-534F34712137Q33965652-87E9F8A8-2BC7-4A37-AA70-E8D13C62ECB3Q34014578-41FB49A3-72F4-4E94-BF99-638840298031Q34018048-CDEBA0EE-3234-48EA-A1B1-FE475FBACA82Q34031994-C1C571DF-A8B2-485B-B6A8-995413F0711AQ34128756-889EAA4E-B7BE-47EB-A0CD-C3F363B43B16Q34145863-788810D0-6ACD-44FB-82C5-AC300640EF56Q34206907-AAD6C8F8-3A2F-4E9F-9FC3-045FE3F52977Q34219208-32A2B3E9-1783-48C9-9615-15A48BDFB4D4
P2860
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Mechanisms of action of bispho ...... nfluence on clinical efficacy.
@ast
Mechanisms of action of bispho ...... nfluence on clinical efficacy.
@en
Mechanisms of action of bispho ...... nfluence on clinical efficacy.
@nl
type
label
Mechanisms of action of bispho ...... nfluence on clinical efficacy.
@ast
Mechanisms of action of bispho ...... nfluence on clinical efficacy.
@en
Mechanisms of action of bispho ...... nfluence on clinical efficacy.
@nl
prefLabel
Mechanisms of action of bispho ...... nfluence on clinical efficacy.
@ast
Mechanisms of action of bispho ...... nfluence on clinical efficacy.
@en
Mechanisms of action of bispho ...... nfluence on clinical efficacy.
@nl
P2860
P1476
Mechanisms of action of bispho ...... influence on clinical efficacy
@en
P2093
F H Ebetino
P2860
P2888
P304
P356
10.1007/S00198-007-0540-8
P407
P577
2008-06-01T00:00:00Z
P5875
P6179
1051377661